Development is based on compounds that affect glucagonopia peptide-1 (GLP-1), which regulates blood sugar and appetite. Scientists have changed the structure of a foreign drug Danuglpron, who had previously had serious side effects in clinical studies.
So far, substances are only tested in cell cultures. After selecting the most promising option, researchers plan to move to pre -clinical and clinical studies.
Previously, Ural Federal University experts, Russian Academy of Sciences and Volgograd Medical University of the Russian Sciences Academy Organic Synthesis Institute and the second type of diabetes have developed new compounds to combat the serious consequences.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
